Category: CNS/Neurology
CNS/Neurology market research reports by GlobalData
-
Delirium - Global Clinical Trials Review, 2024
Delirium - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Delirium - Global Clinical Trials Review, 2024 provides an overview of Delirium Clinical trials scenario. This report provides top line data relating to the clinical trials on Delirium. Report includes an ove ... Read More
-
Social Anxiety Disorder (SAD/Social Phobia) - Global Clinical Trials Review, 2024
Social Anxiety Disorder (SAD/Social Phobia) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Social Anxiety Disorder (SAD/Social Phobia) - Global Clinical Trials Review, 2024 provides an overview of Social Anxiety Disorder (SAD/Social Phobia) Clinical trials scenari ... Read More
-
Migraine: 68-Market Analysis and Sales Forecast
Migraine: 68-Market Analysis and Sales Forecast Summary GlobalData estimates that the value of the migraine market in the 7MM in 2023 was $9.2 billion. This market is defined as sales of acute and preventative treatments including widely used triptans and ergot alkaloids used in abortive treatment a ... Read More
-
Migraine: Seven-Market Drug Forecast and Market Analysis
Migraine: Seven-Market Drug Forecast and Market Analysis Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Migraine market through 2033. GlobalData estimates that the value of the migraine market in the 7MM in 2023 wa ... Read More
-
Clinical Trials: Psychedelic Therapeutics
Clinical Trials: Psychedelic Therapeutics Summary This report provides a review of global psychedelic therapeutic clinical trials derived from the GlobalData’s Clinical Trials Database. The aim of this report is to identify key analyses and segmentations of these trials. As the number of psychedelic ... Read More
-
Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2024
Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2024 Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2024"" provides an overview of Amyotrophic Lateral Scler ... Read More
-
Dementia - Global Clinical Trials Review, 2024
Dementia - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Dementia - Global Clinical Trials Review, 2024" provides an overview of Dementia Clinical trials scenario. This report provides top line data relating to the clinical trials on Dementia. Report includes an ... Read More
-
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update
Amyotrophic Lateral Sclerosis: Opportunity Assessment and Forecast 2019-2029 - Update Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan and Canada) and provides an Excel-based forecast model for the Amyotrophic Lateral Sclerosis (ALS) market through 2029. The prevalenc ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032
Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast 2022-2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Attention Deficit Hyperactivity Disorder (ADHD) market through 2032. The ... Read More
-
Psychedelics Therapeutics Development and Trends, 2024
Psychedelics Therapeutics Development and Trends, 2024 Summary This report provides a summary of the current and future state of the psychedelic therapeutic sector, offering a high-level analysis of key trends and developments within the industry, including regulatory, clinical, and market dynamics. ... Read More
-
Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024
Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Obsessive-Compulsive Disorder - Global Clinical Trials Review, 2024 provides an overview of Obsessive-Compulsive Disorder Clinical trials scenario. This report provides top line data rela ... Read More
-
Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024
Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Borderline Personality Disorder (BPD) - Global Clinical Trials Review, 2024 provides an overview of Borderline Personality Disorder (BPD) Clinical trials scenario. This report pro ... Read More
-
Cell and Gene Therapies in CNS Disorders
Cell and Gene Therapies in CNS Disorders Summary Currently, there are eight cell and gene therapies (CGT) on the market for various central nervous system (CNS) disorders. This includes three gene therapies, two gene-modified cell therapies, and three conditionally approved cell therapies. Novartis’ ... Read More
-
Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024
Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, 2024 provides an overview of Glioblastoma Multiforme (GBM) Clinical trials scenario. This report provides top line data rela ... Read More
-
DTx in Medical - Thematic Research
DTx in Medical - Thematic Research Summary Digital therapeutics (DTx) are software-based interventions that deliver evidence-based therapeutic interventions to patients. The interventions are driven by high-quality software programs to prevent, manage, or treat a medical condition. DTx can be prescr ... Read More
-
Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024
Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024 Summary GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2024 provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report pro ... Read More
-
Neurological Diagnostic and Monitoring Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Neurological Diagnostic and Monitoring Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update Summary GlobalData's Medical Devices sector report, “Neurological Diagnostic and Monitoring Equipment Pipeline Report inclu ... Read More
-
Glioblastoma Multiforme (GBM) - Competitive Landscape
Glioblastoma Multiforme (GBM) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in GBM therapeutics. More than 79,000 incident cases of GBM are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology fore ... Read More
-
Category Innovation Opportunities with Nootropics
Category Innovation Opportunities with Nootropics Summary This report explores how consumers can leverage nootropics to cater to holistic health concerns. Many consumers, especially students, sportspeople, and young professionals consume nootropics or smart drugs to improve focus and memory. The COV ... Read More
-
India Neurology Procedures Count by Segments and Forecast to 2030
India Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “India Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the India Neurology Procedures. The databook report provides procedure volumes within segments - Dur ... Read More
-
Japan Neurology Procedures Count by Segments and Forecast to 2030
Japan Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Japan Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Japan Neurology Procedures. The databook report provides procedure volumes within segments - Dur ... Read More
-
Australia Neurology Procedures Count by Segments and Forecast to 2030
Australia Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Australia Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Australia Neurology Procedures. The databook report provides procedure volumes within se ... Read More
-
Russia Neurology Procedures Count by Segments and Forecast to 2030
Russia Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “Russia Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Russia Neurology Procedures. The databook report provides procedure volumes within segments - ... Read More
-
China Neurology Procedures Count by Segments and Forecast to 2030
China Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “China Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the China Neurology Procedures. The databook report provides procedure volumes within segments - Dur ... Read More
-
South Korea Neurology Procedures Count by Segments and Forecast to 2030
South Korea Neurology Procedures Count by Segments and Forecast to 2030 Summary GlobalData’s “South Korea Neurology Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the South Korea Neurology Procedures. The databook report provides procedure volumes wit ... Read More
Research Assistance
